Zhejiang Haisen Pharmaceutical Co., Ltd. (SHE:001367)

SHE:001367 Revenue

Zhejiang Haisen Pharmaceutical had revenue of 116.78M CNY in the quarter ending September 30, 2025, with 6.74% growth. This brings the company's revenue in the last twelve months to 510.33M, up 17.50% year-over-year. In the year 2024, Zhejiang Haisen Pharmaceutical had annual revenue of 471.51M with 18.63% growth.

• Revenue (ttm): 510.33M
• Revenue Growth: +17.50%
• P/S Ratio: 6.95
• Revenue / Employee: 769.73K
• Employees: 663
• Market Cap: 3.55B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	471.51M	74.06M	18.63%
Dec 31, 2023	397.45M	-25.32M	-5.99%
Jan 1, 2023	422.78M	33.79M	8.69%
Dec 31, 2021	388.98M	104.18M	36.58%
Dec 31, 2020	284.80M	18.47M	6.94%